Loading data for RGC — first visit, this takes a few seconds.
Regencell Bioscience Lim... (RGC)
NasdaqCM: RGC
· Real-Time Price · USD
5.30
-0.14 (-2.57%)
At close: Aug 24, 2026, 8:00 PM
5.30
+0.17%
After-hours: 4:38 PM
The price, the headline numbers and the latest news, in one place.
Regencell Bioscience Limited (RGC) Stock Price, Analysis & Data
-2.57% (1D)
No data available
| Bid | 3.89 |
| Market Cap | 2.62B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -7.05M |
| 1.49 | |
| -0.01 | |
| n/a | |
| n/a | |
| P/B (ttm) | 2645.00 |
| P/S (ttm) | n/a |
| Earnings Date | Jul 16, 2025 |
| Ask | 6.74 |
| Volume | 153,010 |
| Avg. Volume (20D) | 307,633 |
| Open | 5.44 |
| Previous Close | 5.44 |
| Day's Range | 5.22 - 5.50 |
| 52-Week Range | 4.51 - 69.00 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About RGC
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong....
Full Company ProfileFinancial Performance
In 2024, Regencell Bioscience's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -4.3M, a decrease of -26.73%.
Financial StatementsRegencell Bioscience Limited is scheduled to release its earnings on Jul 16, 2025, after market closes.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2